Sandoz enters new era as standalone global leader and European champion in generic and biosimilar medicines
- Spin-off from Novartis successfully completed with first trading day today on SIX Swiss Exchange; Sandoz shares incl
OCALA, Fla., Oct. 03, 2023 (GLOBE NEWSWIRE) — P
SUNN…
Continue ReadingCALGARY, Alberta and SAN ANTONIO, Texas, Oct. 03, 2023 (GLOBE NEWSWIRE) — Eavor Inc. (“Eavor”), the leader in gl